Pictet-Biotech R USD

Register to Unlock Ratings
Performance History30/11/2021
Growth of 1,000 (GBP) Advanced Graph
Pictet-Biotech R USD
Fund12.8-10.224.923.1-8.4
+/-Cat2.5-2.24.7-2.9-1.3
+/-B’mrk1.7-7.04.70.6-13.0
 
Key Stats
NAV
02/12/2021
 USD 778.83
Day Change -1.28%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0112497440
Fund Size (Mil)
03/12/2021
 USD 1935.14
Share Class Size (Mil)
02/12/2021
 USD 278.11
Max Initial Charge 5.00%
Ongoing Charge
11/05/2021
  2.70%
Investment Objective: Pictet-Biotech R USD
This Compartment applies a capital growth strategy by investing at least two-thirds of its total assets/total wealth in equities or similar securities issued by biopharmaceutical companies throughout the world (including emerging countries). However, in light of the particularly innovative nature of the pharmaceutical industry in North America and Western Europe, the vast majority of investments will be made in these regions. To capitalise on particularly innovative projects in the pharmaceuticals field, the Biotech Compartment may invest up to 10% of its net assets in Private Equity and/or unlisted securities.
Returns
Trailing Returns (GBP)02/12/2021
YTD-10.31
3 Years Annualised7.61
5 Years Annualised6.95
10 Years Annualised13.16
12 Month Yield 0.00
Management
Manager Name
Start Date
Tazio Storni
26/05/2016
Marco Minonne
01/06/2020
Click here to see others
Inception Date
27/06/2000
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
MSCI ACWI NR EURNASDAQ Biotechnology TR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  Pictet-Biotech R USD31/10/2021
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock98.470.0098.47
Bond0.210.130.09
Property0.000.000.00
Cash1.870.431.45
Other0.000.000.00
Top 5 Regions%
United States88.48
Europe - ex Euro3.63
Asia - Emerging3.20
Eurozone2.07
Canada1.57
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Horizon Therapeutics PLCHealthcareHealthcare6.24
Seagen Inc Ordinary SharesHealthcareHealthcare6.00
Regeneron Pharmaceuticals IncHealthcareHealthcare5.17
Vertex Pharmaceuticals IncHealthcareHealthcare5.10
Biogen IncHealthcareHealthcare3.26
Pictet-Biotech R USD

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)